nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—Clonidine—glaucoma	0.121	0.194	CbGbCtD
Albendazole—CYP1A2—Betaxolol—glaucoma	0.0987	0.158	CbGbCtD
Albendazole—CYP3A4—Pilocarpine—glaucoma	0.058	0.0931	CbGbCtD
Albendazole—ABCB1—Timolol—glaucoma	0.0556	0.0893	CbGbCtD
Albendazole—CYP1A2—Clonidine—glaucoma	0.0541	0.0868	CbGbCtD
Albendazole—ABCB1—Clonidine—glaucoma	0.0473	0.0759	CbGbCtD
Albendazole—CYP3A4—Brinzolamide—glaucoma	0.0455	0.0731	CbGbCtD
Albendazole—CYP3A4—Dorzolamide—glaucoma	0.044	0.0706	CbGbCtD
Albendazole—CYP3A4—Methazolamide—glaucoma	0.0392	0.0629	CbGbCtD
Albendazole—CYP3A4—Acetazolamide—glaucoma	0.0313	0.0503	CbGbCtD
Albendazole—CYP3A4—Clonidine—glaucoma	0.0283	0.0455	CbGbCtD
Albendazole—TUBA1A—optic choroid—glaucoma	0.0107	0.493	CbGeAlD
Albendazole—Alopecia reversible—Timolol—glaucoma	0.00705	0.0301	CcSEcCtD
Albendazole—Aplastic anaemia—Methazolamide—glaucoma	0.00442	0.0189	CcSEcCtD
Albendazole—TUBA1A—Centrosome maturation—FGFR1OP—glaucoma	0.00384	0.0318	CbGpPWpGaD
Albendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00352	0.0292	CbGpPWpGaD
Albendazole—TUBA1A—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00345	0.0286	CbGpPWpGaD
Albendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00331	0.0274	CbGpPWpGaD
Albendazole—Aplastic anaemia—Acetazolamide—glaucoma	0.00306	0.0131	CcSEcCtD
Albendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.00287	0.0238	CbGpPWpGaD
Albendazole—Pancytopenia—Methazolamide—glaucoma	0.0028	0.012	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Levobunolol—glaucoma	0.00272	0.0116	CcSEcCtD
Albendazole—Agranulocytosis—Diclofenamide—glaucoma	0.00267	0.0114	CcSEcCtD
Albendazole—Vomiting—Physostigmine—glaucoma	0.00266	0.0114	CcSEcCtD
Albendazole—TUBA1A—G2/M Transition—FGFR1OP—glaucoma	0.00265	0.0219	CbGpPWpGaD
Albendazole—Hypersensitivity—Dipivefrin—glaucoma	0.00262	0.0112	CcSEcCtD
Albendazole—TUBB4B—Loss of Nlp from mitotic centrosomes—FGFR1OP—glaucoma	0.00262	0.0217	CbGpPWpGaD
Albendazole—TUBA1A—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.00261	0.0216	CbGpPWpGaD
Albendazole—Stevens-Johnson syndrome—Methazolamide—glaucoma	0.00261	0.0111	CcSEcCtD
Albendazole—TUBA1A—G2/M Transition—RAB8A—glaucoma	0.00249	0.0206	CbGpPWpGaD
Albendazole—Nausea—Physostigmine—glaucoma	0.00249	0.0106	CcSEcCtD
Albendazole—Agranulocytosis—Methazolamide—glaucoma	0.00245	0.0105	CcSEcCtD
Albendazole—TUBA1A—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00245	0.0203	CbGpPWpGaD
Albendazole—Liver function test abnormal—Bimatoprost—glaucoma	0.00236	0.0101	CcSEcCtD
Albendazole—Erythema multiforme—Levobunolol—glaucoma	0.00233	0.00996	CcSEcCtD
Albendazole—TUBB4B—Centrosome maturation—FGFR1OP—glaucoma	0.00232	0.0192	CbGpPWpGaD
Albendazole—Erythema multiforme—Methazolamide—glaucoma	0.00223	0.00954	CcSEcCtD
Albendazole—Alopecia—Levobunolol—glaucoma	0.00218	0.0093	CcSEcCtD
Albendazole—TUBA1A—G2/M Transition—OPTN—glaucoma	0.00216	0.0178	CbGpPWpGaD
Albendazole—TUBA1A—eye—glaucoma	0.00215	0.0991	CbGeAlD
Albendazole—TUBA1A—retina—glaucoma	0.00213	0.0983	CbGeAlD
Albendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00213	0.0176	CbGpPWpGaD
Albendazole—TUBA1A—Mitotic G2-G2/M phases—OPTN—glaucoma	0.00213	0.0176	CbGpPWpGaD
Albendazole—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00211	0.0175	CbGpPWpGaD
Albendazole—TUBB4B—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00209	0.0173	CbGpPWpGaD
Albendazole—TUBA1A—connective tissue—glaucoma	0.00207	0.0955	CbGeAlD
Albendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00201	0.0167	CbGpPWpGaD
Albendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.002	0.0166	CbGpPWpGaD
Albendazole—Leukopenia—Diclofenamide—glaucoma	0.002	0.00854	CcSEcCtD
Albendazole—Liver function test abnormal—Brinzolamide—glaucoma	0.00197	0.0084	CcSEcCtD
Albendazole—Liver function test abnormal—Pilocarpine—glaucoma	0.00189	0.00807	CcSEcCtD
Albendazole—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00187	0.0155	CbGpPWpGaD
Albendazole—Vertigo—Methazolamide—glaucoma	0.00185	0.00789	CcSEcCtD
Albendazole—Leukopenia—Methazolamide—glaucoma	0.00184	0.00786	CcSEcCtD
Albendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00183	0.0152	CbGpPWpGaD
Albendazole—CYP1A1—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00183	0.0152	CbGpPWpGaD
Albendazole—Stevens-Johnson syndrome—Acetazolamide—glaucoma	0.00181	0.00771	CcSEcCtD
Albendazole—Thrombocytopenia—Diclofenamide—glaucoma	0.00178	0.00762	CcSEcCtD
Albendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.00173	0.0144	CbGpPWpGaD
Albendazole—Hepatobiliary disease—Acetazolamide—glaucoma	0.00172	0.00736	CcSEcCtD
Albendazole—Agranulocytosis—Acetazolamide—glaucoma	0.0017	0.00726	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00168	0.00719	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Dorzolamide—glaucoma	0.00165	0.00707	CcSEcCtD
Albendazole—TUBB4B—G2/M Transition—FGFR1OP—glaucoma	0.0016	0.0132	CbGpPWpGaD
Albendazole—Skin disorder—Latanoprost—glaucoma	0.00158	0.00674	CcSEcCtD
Albendazole—TUBB4B—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.00157	0.013	CbGpPWpGaD
Albendazole—Agranulocytosis—Dorzolamide—glaucoma	0.00156	0.00665	CcSEcCtD
Albendazole—Hepatobiliary disease—Brinzolamide—glaucoma	0.00155	0.00663	CcSEcCtD
Albendazole—Erythema multiforme—Acetazolamide—glaucoma	0.00155	0.0066	CcSEcCtD
Albendazole—Liver function test abnormal—Clonidine—glaucoma	0.00151	0.00644	CcSEcCtD
Albendazole—TUBB4B—G2/M Transition—RAB8A—glaucoma	0.0015	0.0124	CbGpPWpGaD
Albendazole—TUBB4B—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00148	0.0123	CbGpPWpGaD
Albendazole—Hypersensitivity—Metipranolol—glaucoma	0.00147	0.0063	CcSEcCtD
Albendazole—Urinary tract disorder—Travoprost—glaucoma	0.00147	0.00629	CcSEcCtD
Albendazole—Urethral disorder—Travoprost—glaucoma	0.00146	0.00625	CcSEcCtD
Albendazole—Urinary tract disorder—Brinzolamide—glaucoma	0.00145	0.00621	CcSEcCtD
Albendazole—Urethral disorder—Brinzolamide—glaucoma	0.00144	0.00617	CcSEcCtD
Albendazole—Body temperature increased—Diclofenamide—glaucoma	0.00144	0.00615	CcSEcCtD
Albendazole—TUBB4B—eye—glaucoma	0.00143	0.0661	CbGeAlD
Albendazole—TUBB4B—retina—glaucoma	0.00142	0.0655	CbGeAlD
Albendazole—Immune system disorder—Brimonidine—glaucoma	0.00142	0.00605	CcSEcCtD
Albendazole—Erythema multiforme—Dorzolamide—glaucoma	0.00142	0.00605	CcSEcCtD
Albendazole—Hepatitis—Pilocarpine—glaucoma	0.00142	0.00605	CcSEcCtD
Albendazole—Abdominal pain—Carbachol—glaucoma	0.00141	0.00601	CcSEcCtD
Albendazole—Body temperature increased—Carbachol—glaucoma	0.00141	0.00601	CcSEcCtD
Albendazole—Urticaria—Levobunolol—glaucoma	0.00139	0.00594	CcSEcCtD
Albendazole—Vertigo—Bimatoprost—glaucoma	0.00139	0.00592	CcSEcCtD
Albendazole—TUBB4B—connective tissue—glaucoma	0.00138	0.0637	CbGeAlD
Albendazole—Hypersensitivity—Carteolol—glaucoma	0.00137	0.00583	CcSEcCtD
Albendazole—CYP1A1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00136	0.0113	CbGpPWpGaD
Albendazole—Immune system disorder—Travoprost—glaucoma	0.00135	0.00576	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00135	0.00575	CcSEcCtD
Albendazole—Urticaria—Methazolamide—glaucoma	0.00133	0.00569	CcSEcCtD
Albendazole—Immune system disorder—Brinzolamide—glaucoma	0.00133	0.00568	CcSEcCtD
Albendazole—Body temperature increased—Methazolamide—glaucoma	0.00133	0.00567	CcSEcCtD
Albendazole—Alopecia—Dorzolamide—glaucoma	0.00132	0.00566	CcSEcCtD
Albendazole—Dizziness—Metipranolol—glaucoma	0.00132	0.00565	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.0013	0.00557	CcSEcCtD
Albendazole—TUBB4B—G2/M Transition—OPTN—glaucoma	0.0013	0.0108	CbGpPWpGaD
Albendazole—Alopecia—Brinzolamide—glaucoma	0.0013	0.00556	CcSEcCtD
Albendazole—Hypersensitivity—Levobunolol—glaucoma	0.00129	0.00551	CcSEcCtD
Albendazole—TUBB4B—Mitotic G2-G2/M phases—OPTN—glaucoma	0.00128	0.0106	CbGpPWpGaD
Albendazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00128	0.0106	CbGpPWpGaD
Albendazole—TUBA1A—p73 transcription factor network—NTRK1—glaucoma	0.00128	0.0106	CbGpPWpGaD
Albendazole—Leukopenia—Acetazolamide—glaucoma	0.00127	0.00544	CcSEcCtD
Albendazole—Rash—Metipranolol—glaucoma	0.00126	0.00539	CcSEcCtD
Albendazole—Skin disorder—Apraclonidine—glaucoma	0.00126	0.00539	CcSEcCtD
Albendazole—Dermatitis—Metipranolol—glaucoma	0.00126	0.00538	CcSEcCtD
Albendazole—Headache—Metipranolol—glaucoma	0.00125	0.00535	CcSEcCtD
Albendazole—Alopecia—Pilocarpine—glaucoma	0.00125	0.00534	CcSEcCtD
Albendazole—Dizziness—Carteolol—glaucoma	0.00123	0.00524	CcSEcCtD
Albendazole—Skin disorder—Bimatoprost—glaucoma	0.00122	0.00522	CcSEcCtD
Albendazole—Dizziness—Diclofenamide—glaucoma	0.0012	0.00515	CcSEcCtD
Albendazole—Nausea—Metipranolol—glaucoma	0.00119	0.00508	CcSEcCtD
Albendazole—Dizziness—Carbachol—glaucoma	0.00118	0.00502	CcSEcCtD
Albendazole—Vertigo—Dorzolamide—glaucoma	0.00117	0.00501	CcSEcCtD
Albendazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00117	0.00966	CbGpPWpGaD
Albendazole—Vertigo—Travoprost—glaucoma	0.00117	0.00498	CcSEcCtD
Albendazole—Headache—Carteolol—glaucoma	0.00116	0.00496	CcSEcCtD
Albendazole—Vomiting—Diclofenamide—glaucoma	0.00116	0.00495	CcSEcCtD
Albendazole—Dizziness—Levobunolol—glaucoma	0.00116	0.00495	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00115	0.00493	CcSEcCtD
Albendazole—Vertigo—Brinzolamide—glaucoma	0.00115	0.00492	CcSEcCtD
Albendazole—Rash—Diclofenamide—glaucoma	0.00115	0.00491	CcSEcCtD
Albendazole—Headache—Diclofenamide—glaucoma	0.00114	0.00488	CcSEcCtD
Albendazole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00114	0.00945	CbGpPWpGaD
Albendazole—Thrombocytopenia—Acetazolamide—glaucoma	0.00114	0.00486	CcSEcCtD
Albendazole—Vomiting—Carbachol—glaucoma	0.00113	0.00483	CcSEcCtD
Albendazole—Hepatitis—Clonidine—glaucoma	0.00113	0.00483	CcSEcCtD
Albendazole—Rash—Carbachol—glaucoma	0.00112	0.00479	CcSEcCtD
Albendazole—Dermatitis—Carbachol—glaucoma	0.00112	0.00479	CcSEcCtD
Albendazole—Headache—Carbachol—glaucoma	0.00111	0.00476	CcSEcCtD
Albendazole—Leukopenia—Pilocarpine—glaucoma	0.0011	0.00471	CcSEcCtD
Albendazole—Nausea—Carteolol—glaucoma	0.0011	0.0047	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.0011	0.00469	CcSEcCtD
Albendazole—Headache—Levobunolol—glaucoma	0.0011	0.00469	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00108	0.00463	CcSEcCtD
Albendazole—Skin disorder—Brimonidine—glaucoma	0.00108	0.00462	CcSEcCtD
Albendazole—Nausea—Diclofenamide—glaucoma	0.00108	0.00462	CcSEcCtD
Albendazole—Dizziness—Latanoprost—glaucoma	0.00107	0.00459	CcSEcCtD
Albendazole—Liver function test abnormal—Timolol—glaucoma	0.00107	0.00458	CcSEcCtD
Albendazole—Vomiting—Methazolamide—glaucoma	0.00107	0.00456	CcSEcCtD
Albendazole—Gastrointestinal pain—Apraclonidine—glaucoma	0.00106	0.00453	CcSEcCtD
Albendazole—Rash—Methazolamide—glaucoma	0.00106	0.00452	CcSEcCtD
Albendazole—Dermatitis—Methazolamide—glaucoma	0.00106	0.00451	CcSEcCtD
Albendazole—Nausea—Carbachol—glaucoma	0.00106	0.00451	CcSEcCtD
Albendazole—CYP1A1—Estrogen metabolism—CYP1B1—glaucoma	0.00105	0.00871	CbGpPWpGaD
Albendazole—Headache—Methazolamide—glaucoma	0.00105	0.00449	CcSEcCtD
Albendazole—Nausea—Levobunolol—glaucoma	0.00104	0.00444	CcSEcCtD
Albendazole—Skin disorder—Travoprost—glaucoma	0.00103	0.0044	CcSEcCtD
Albendazole—Abdominal pain—Apraclonidine—glaucoma	0.00103	0.00438	CcSEcCtD
Albendazole—Rash—Latanoprost—glaucoma	0.00102	0.00437	CcSEcCtD
Albendazole—Agranulocytosis—Betaxolol—glaucoma	0.00102	0.00437	CcSEcCtD
Albendazole—Dermatitis—Latanoprost—glaucoma	0.00102	0.00437	CcSEcCtD
Albendazole—Headache—Latanoprost—glaucoma	0.00102	0.00435	CcSEcCtD
Albendazole—Skin disorder—Brinzolamide—glaucoma	0.00102	0.00434	CcSEcCtD
Albendazole—TUBA1A—p73 transcription factor network—FAS—glaucoma	0.001	0.00832	CbGpPWpGaD
Albendazole—Alopecia—Clonidine—glaucoma	0.000999	0.00427	CcSEcCtD
Albendazole—Nausea—Methazolamide—glaucoma	0.000997	0.00426	CcSEcCtD
Albendazole—Thrombocytopenia—Pilocarpine—glaucoma	0.000985	0.00421	CcSEcCtD
Albendazole—TUBA1A—Metabolism of proteins—DHPS—glaucoma	0.000973	0.00806	CbGpPWpGaD
Albendazole—Hypersensitivity—Apraclonidine—glaucoma	0.000957	0.00409	CcSEcCtD
Albendazole—CYP1A1—Tamoxifen metabolism—CYP1B1—glaucoma	0.00093	0.0077	CbGpPWpGaD
Albendazole—Urticaria—Acetazolamide—glaucoma	0.000923	0.00394	CcSEcCtD
Albendazole—Body temperature increased—Acetazolamide—glaucoma	0.000918	0.00392	CcSEcCtD
Albendazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000901	0.00746	CbGpPWpGaD
Albendazole—Immune system disorder—Betaxolol—glaucoma	0.000889	0.0038	CcSEcCtD
Albendazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000881	0.00729	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Dorzolamide—glaucoma	0.00087	0.00372	CcSEcCtD
Albendazole—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00087	0.0072	CbGpPWpGaD
Albendazole—Alopecia—Betaxolol—glaucoma	0.00087	0.00372	CcSEcCtD
Albendazole—Gastrointestinal pain—Travoprost—glaucoma	0.000867	0.0037	CcSEcCtD
Albendazole—Dizziness—Apraclonidine—glaucoma	0.000859	0.00367	CcSEcCtD
Albendazole—Urticaria—Dorzolamide—glaucoma	0.000846	0.00361	CcSEcCtD
Albendazole—Abdominal pain—Dorzolamide—glaucoma	0.000842	0.00359	CcSEcCtD
Albendazole—Body temperature increased—Dorzolamide—glaucoma	0.000842	0.00359	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000841	0.00696	CbGpPWpGaD
Albendazole—CYP1A1—Estrogen metabolism—GSTM1—glaucoma	0.000841	0.00696	CbGpPWpGaD
Albendazole—Abdominal pain—Travoprost—glaucoma	0.000838	0.00358	CcSEcCtD
Albendazole—Agranulocytosis—Timolol—glaucoma	0.000836	0.00357	CcSEcCtD
Albendazole—Dizziness—Bimatoprost—glaucoma	0.000832	0.00356	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000832	0.00355	CcSEcCtD
Albendazole—Urticaria—Brinzolamide—glaucoma	0.000831	0.00355	CcSEcCtD
Albendazole—Vomiting—Apraclonidine—glaucoma	0.000826	0.00353	CcSEcCtD
Albendazole—Gastrointestinal pain—Pilocarpine—glaucoma	0.000823	0.00351	CcSEcCtD
Albendazole—Hypersensitivity—Brimonidine—glaucoma	0.000821	0.00351	CcSEcCtD
Albendazole—Dermatitis—Apraclonidine—glaucoma	0.000818	0.00349	CcSEcCtD
Albendazole—Headache—Apraclonidine—glaucoma	0.000813	0.00347	CcSEcCtD
Albendazole—Body temperature increased—Pilocarpine—glaucoma	0.000795	0.0034	CcSEcCtD
Albendazole—Abdominal pain—Pilocarpine—glaucoma	0.000795	0.0034	CcSEcCtD
Albendazole—Rash—Bimatoprost—glaucoma	0.000794	0.00339	CcSEcCtD
Albendazole—Dermatitis—Bimatoprost—glaucoma	0.000793	0.00339	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000791	0.00655	CbGpPWpGaD
Albendazole—Headache—Bimatoprost—glaucoma	0.000789	0.00337	CcSEcCtD
Albendazole—Thrombocytopenia—Clonidine—glaucoma	0.000786	0.00336	CcSEcCtD
Albendazole—Hypersensitivity—Dorzolamide—glaucoma	0.000784	0.00335	CcSEcCtD
Albendazole—Hypersensitivity—Travoprost—glaucoma	0.000781	0.00334	CcSEcCtD
Albendazole—Skin disorder—Clonidine—glaucoma	0.00078	0.00333	CcSEcCtD
Albendazole—Nausea—Apraclonidine—glaucoma	0.000771	0.00329	CcSEcCtD
Albendazole—Hypersensitivity—Brinzolamide—glaucoma	0.000771	0.00329	CcSEcCtD
Albendazole—Vertigo—Betaxolol—glaucoma	0.00077	0.00329	CcSEcCtD
Albendazole—Dizziness—Acetazolamide—glaucoma	0.000768	0.00328	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—FGFR1OP—glaucoma	0.000752	0.00623	CbGpPWpGaD
Albendazole—Nausea—Bimatoprost—glaucoma	0.000748	0.00319	CcSEcCtD
Albendazole—Hypersensitivity—Pilocarpine—glaucoma	0.000741	0.00317	CcSEcCtD
Albendazole—Vomiting—Acetazolamide—glaucoma	0.000738	0.00315	CcSEcCtD
Albendazole—Dizziness—Brimonidine—glaucoma	0.000737	0.00315	CcSEcCtD
Albendazole—Headache—Acetazolamide—glaucoma	0.000728	0.00311	CcSEcCtD
Albendazole—Immune system disorder—Timolol—glaucoma	0.000726	0.0031	CcSEcCtD
Albendazole—TUBB4B—Transmembrane transport of small molecules—PEX19—glaucoma	0.000726	0.00601	CbGpPWpGaD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000724	0.00309	CcSEcCtD
Albendazole—CYP1A1—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000718	0.00594	CbGpPWpGaD
Albendazole—Alopecia—Timolol—glaucoma	0.000711	0.00304	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—RAB8A—glaucoma	0.000707	0.00586	CbGpPWpGaD
Albendazole—Dizziness—Dorzolamide—glaucoma	0.000704	0.00301	CcSEcCtD
Albendazole—Rash—Brimonidine—glaucoma	0.000703	0.003	CcSEcCtD
Albendazole—Dermatitis—Brimonidine—glaucoma	0.000702	0.003	CcSEcCtD
Albendazole—Dizziness—Travoprost—glaucoma	0.000701	0.00299	CcSEcCtD
Albendazole—Headache—Brimonidine—glaucoma	0.000698	0.00298	CcSEcCtD
Albendazole—Dizziness—Brinzolamide—glaucoma	0.000692	0.00296	CcSEcCtD
Albendazole—Nausea—Acetazolamide—glaucoma	0.00069	0.00295	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000686	0.00568	CbGpPWpGaD
Albendazole—Thrombocytopenia—Betaxolol—glaucoma	0.000685	0.00292	CcSEcCtD
Albendazole—Skin disorder—Betaxolol—glaucoma	0.000679	0.0029	CcSEcCtD
Albendazole—Vomiting—Dorzolamide—glaucoma	0.000677	0.00289	CcSEcCtD
Albendazole—Rash—Dorzolamide—glaucoma	0.000671	0.00287	CcSEcCtD
Albendazole—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000671	0.00555	CbGpPWpGaD
Albendazole—Dermatitis—Dorzolamide—glaucoma	0.000671	0.00286	CcSEcCtD
Albendazole—Rash—Travoprost—glaucoma	0.000668	0.00285	CcSEcCtD
Albendazole—Dermatitis—Travoprost—glaucoma	0.000668	0.00285	CcSEcCtD
Albendazole—Headache—Dorzolamide—glaucoma	0.000667	0.00285	CcSEcCtD
Albendazole—Vomiting—Brinzolamide—glaucoma	0.000665	0.00284	CcSEcCtD
Albendazole—Dizziness—Pilocarpine—glaucoma	0.000665	0.00284	CcSEcCtD
Albendazole—Headache—Travoprost—glaucoma	0.000664	0.00284	CcSEcCtD
Albendazole—Nausea—Brimonidine—glaucoma	0.000662	0.00283	CcSEcCtD
Albendazole—Rash—Brinzolamide—glaucoma	0.00066	0.00282	CcSEcCtD
Albendazole—Dermatitis—Brinzolamide—glaucoma	0.000659	0.00282	CcSEcCtD
Albendazole—Gastrointestinal pain—Clonidine—glaucoma	0.000657	0.00281	CcSEcCtD
Albendazole—Headache—Brinzolamide—glaucoma	0.000656	0.0028	CcSEcCtD
Albendazole—Vomiting—Pilocarpine—glaucoma	0.00064	0.00273	CcSEcCtD
Albendazole—Urticaria—Clonidine—glaucoma	0.000638	0.00273	CcSEcCtD
Albendazole—Body temperature increased—Clonidine—glaucoma	0.000635	0.00271	CcSEcCtD
Albendazole—Abdominal pain—Clonidine—glaucoma	0.000635	0.00271	CcSEcCtD
Albendazole—Rash—Pilocarpine—glaucoma	0.000634	0.00271	CcSEcCtD
Albendazole—Dermatitis—Pilocarpine—glaucoma	0.000634	0.00271	CcSEcCtD
Albendazole—Nausea—Dorzolamide—glaucoma	0.000632	0.0027	CcSEcCtD
Albendazole—Headache—Pilocarpine—glaucoma	0.00063	0.00269	CcSEcCtD
Albendazole—Nausea—Travoprost—glaucoma	0.00063	0.00269	CcSEcCtD
Albendazole—Vertigo—Timolol—glaucoma	0.000629	0.00269	CcSEcCtD
Albendazole—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000623	0.00516	CbGpPWpGaD
Albendazole—Nausea—Brinzolamide—glaucoma	0.000622	0.00266	CcSEcCtD
Albendazole—TUBA1A—Cell Cycle—OPTN—glaucoma	0.000613	0.00508	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CTSA—glaucoma	0.000607	0.00503	CbGpPWpGaD
Albendazole—Nausea—Pilocarpine—glaucoma	0.000597	0.00255	CcSEcCtD
Albendazole—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000593	0.00491	CbGpPWpGaD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000592	0.00253	CcSEcCtD
Albendazole—Hypersensitivity—Clonidine—glaucoma	0.000592	0.00253	CcSEcCtD
Albendazole—TUBB4B—Metabolism of proteins—DHPS—glaucoma	0.000588	0.00486	CbGpPWpGaD
Albendazole—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000581	0.00481	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—ACE2—glaucoma	0.000559	0.00463	CbGpPWpGaD
Albendazole—Urticaria—Betaxolol—glaucoma	0.000556	0.00237	CcSEcCtD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000555	0.0046	CbGpPWpGaD
Albendazole—Skin disorder—Timolol—glaucoma	0.000555	0.00237	CcSEcCtD
Albendazole—Body temperature increased—Betaxolol—glaucoma	0.000553	0.00236	CcSEcCtD
Albendazole—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000536	0.00444	CbGpPWpGaD
Albendazole—Dizziness—Clonidine—glaucoma	0.000531	0.00227	CcSEcCtD
Albendazole—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000518	0.00428	CbGpPWpGaD
Albendazole—Hypersensitivity—Betaxolol—glaucoma	0.000515	0.0022	CcSEcCtD
Albendazole—Vomiting—Clonidine—glaucoma	0.000511	0.00218	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000508	0.00421	CbGpPWpGaD
Albendazole—Rash—Clonidine—glaucoma	0.000506	0.00216	CcSEcCtD
Albendazole—Dermatitis—Clonidine—glaucoma	0.000506	0.00216	CcSEcCtD
Albendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000505	0.00418	CbGpPWpGaD
Albendazole—Headache—Clonidine—glaucoma	0.000503	0.00215	CcSEcCtD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000497	0.00411	CbGpPWpGaD
Albendazole—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000497	0.00411	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000497	0.00411	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00049	0.00406	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000478	0.00395	CbGpPWpGaD
Albendazole—Nausea—Clonidine—glaucoma	0.000477	0.00204	CcSEcCtD
Albendazole—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000472	0.00391	CbGpPWpGaD
Albendazole—Gastrointestinal pain—Timolol—glaucoma	0.000467	0.002	CcSEcCtD
Albendazole—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000464	0.00384	CbGpPWpGaD
Albendazole—Dizziness—Betaxolol—glaucoma	0.000462	0.00198	CcSEcCtD
Albendazole—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000458	0.00379	CbGpPWpGaD
Albendazole—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000458	0.00379	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—FGFR1OP—glaucoma	0.000454	0.00376	CbGpPWpGaD
Albendazole—Urticaria—Timolol—glaucoma	0.000454	0.00194	CcSEcCtD
Albendazole—Body temperature increased—Timolol—glaucoma	0.000452	0.00193	CcSEcCtD
Albendazole—Abdominal pain—Timolol—glaucoma	0.000452	0.00193	CcSEcCtD
Albendazole—Vomiting—Betaxolol—glaucoma	0.000445	0.0019	CcSEcCtD
Albendazole—Rash—Betaxolol—glaucoma	0.000441	0.00188	CcSEcCtD
Albendazole—Dermatitis—Betaxolol—glaucoma	0.000441	0.00188	CcSEcCtD
Albendazole—Headache—Betaxolol—glaucoma	0.000438	0.00187	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle—RAB8A—glaucoma	0.000427	0.00354	CbGpPWpGaD
Albendazole—Hypersensitivity—Timolol—glaucoma	0.000421	0.0018	CcSEcCtD
Albendazole—Nausea—Betaxolol—glaucoma	0.000415	0.00177	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle, Mitotic—OPTN—glaucoma	0.000414	0.00343	CbGpPWpGaD
Albendazole—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000414	0.00342	CbGpPWpGaD
Albendazole—ABCB1—retina—glaucoma	0.000413	0.019	CbGeAlD
Albendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000403	0.00334	CbGpPWpGaD
Albendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000401	0.00332	CbGpPWpGaD
Albendazole—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000396	0.00328	CbGpPWpGaD
Albendazole—Dizziness—Timolol—glaucoma	0.000378	0.00161	CcSEcCtD
Albendazole—TUBB4B—Cell Cycle—OPTN—glaucoma	0.00037	0.00307	CbGpPWpGaD
Albendazole—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.00037	0.00307	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CTSA—glaucoma	0.000367	0.00304	CbGpPWpGaD
Albendazole—Vomiting—Timolol—glaucoma	0.000363	0.00155	CcSEcCtD
Albendazole—Rash—Timolol—glaucoma	0.00036	0.00154	CcSEcCtD
Albendazole—Dermatitis—Timolol—glaucoma	0.00036	0.00154	CcSEcCtD
Albendazole—Headache—Timolol—glaucoma	0.000358	0.00153	CcSEcCtD
Albendazole—Nausea—Timolol—glaucoma	0.000339	0.00145	CcSEcCtD
Albendazole—TUBB4B—Metabolism of proteins—ACE2—glaucoma	0.000338	0.00279	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000327	0.00271	CbGpPWpGaD
Albendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000325	0.00269	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000317	0.00262	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000317	0.00262	CbGpPWpGaD
Albendazole—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000317	0.00262	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CCND2—glaucoma	0.000315	0.00261	CbGpPWpGaD
Albendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000311	0.00258	CbGpPWpGaD
Albendazole—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000301	0.00249	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—PAX6—glaucoma	0.000298	0.00247	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000296	0.00245	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000282	0.00234	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CCND2—glaucoma	0.000282	0.00233	CbGpPWpGaD
Albendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000256	0.00212	CbGpPWpGaD
Albendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000253	0.00209	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN2B—glaucoma	0.000252	0.00209	CbGpPWpGaD
Albendazole—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	0.000247	0.00205	CbGpPWpGaD
Albendazole—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000244	0.00202	CbGpPWpGaD
Albendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000242	0.002	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.00024	0.00199	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000239	0.00198	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000236	0.00196	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000224	0.00185	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00022	0.00183	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTT1—glaucoma	0.000217	0.0018	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000212	0.00175	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000212	0.00175	CbGpPWpGaD
Albendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000209	0.00173	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000208	0.00172	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000207	0.00171	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000198	0.00164	CbGpPWpGaD
Albendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000195	0.00161	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND2—glaucoma	0.00019	0.00157	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—FAS—glaucoma	0.000184	0.00153	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—C3—glaucoma	0.000182	0.0015	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—PAX6—glaucoma	0.00018	0.00149	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000176	0.00146	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—CYP1B1—glaucoma	0.000173	0.00143	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	0.00017	0.00141	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.00017	0.00141	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND2—glaucoma	0.00017	0.00141	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MMP1—glaucoma	0.00017	0.0014	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000167	0.00138	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000161	0.00134	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000161	0.00134	CbGpPWpGaD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000161	0.00133	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00016	0.00133	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000156	0.00129	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2B—glaucoma	0.000152	0.00126	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NARFL—glaucoma	0.000152	0.00126	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA5A—glaucoma	0.000152	0.00126	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000151	0.00125	CbGpPWpGaD
Albendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000151	0.00125	CbGpPWpGaD
Albendazole—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000151	0.00125	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000149	0.00123	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN2A—glaucoma	0.000144	0.00119	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000143	0.00118	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000143	0.00118	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000138	0.00115	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTM1—glaucoma	0.000138	0.00114	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	0.000136	0.00113	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000135	0.00112	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000135	0.00112	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000133	0.0011	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—MMP2—glaucoma	0.000131	0.00109	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN1B—glaucoma	0.000128	0.00106	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NARFL—glaucoma	0.000121	0.00101	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA5A—glaucoma	0.000121	0.00101	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000116	0.000961	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000112	0.00093	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.00011	0.000912	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000109	0.0009	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000107	0.000886	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000107	0.000884	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000106	0.00088	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000105	0.000873	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000103	0.000852	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP1—glaucoma	0.000102	0.000848	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.94e-05	0.000823	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—glaucoma	9.75e-05	0.000807	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NARFL—glaucoma	9.7e-05	0.000803	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA5A—glaucoma	9.7e-05	0.000803	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	9.63e-05	0.000797	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	9.63e-05	0.000797	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—glaucoma	9.13e-05	0.000756	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.1e-05	0.000753	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTM1—glaucoma	8.81e-05	0.000729	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—glaucoma	8.72e-05	0.000722	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	8.69e-05	0.000719	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—glaucoma	8.63e-05	0.000715	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1B1—glaucoma	8.51e-05	0.000704	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	8.39e-05	0.000694	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—glaucoma	8.03e-05	0.000665	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP2—glaucoma	7.93e-05	0.000656	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—glaucoma	7.83e-05	0.000648	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	7.78e-05	0.000644	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN1B—glaucoma	7.72e-05	0.000639	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NARFL—glaucoma	7.48e-05	0.000619	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA5A—glaucoma	7.48e-05	0.000619	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA1—glaucoma	7.43e-05	0.000615	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.27e-05	0.000602	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CTSA—glaucoma	7.19e-05	0.000595	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTM1—glaucoma	6.8e-05	0.000563	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA2—glaucoma	6.79e-05	0.000562	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	6.71e-05	0.000555	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.64e-05	0.000549	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.64e-05	0.000549	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA1—glaucoma	5.93e-05	0.000491	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CTSA—glaucoma	5.74e-05	0.000475	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.72e-05	0.000474	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA2—glaucoma	5.42e-05	0.000449	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.42e-05	0.000449	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—glaucoma	4.85e-05	0.000402	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TXN—glaucoma	4.79e-05	0.000396	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA1—glaucoma	4.74e-05	0.000392	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CTSA—glaucoma	4.59e-05	0.00038	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.51e-05	0.000373	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.37e-05	0.000361	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA2—glaucoma	4.33e-05	0.000358	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.33e-05	0.000358	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.23e-05	0.00035	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.23e-05	0.00035	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.86e-05	0.00032	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TXN—glaucoma	3.82e-05	0.000316	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—glaucoma	3.71e-05	0.000307	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA1—glaucoma	3.65e-05	0.000302	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CTSA—glaucoma	3.54e-05	0.000293	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.41e-05	0.000282	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA2—glaucoma	3.34e-05	0.000277	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TXN—glaucoma	3.05e-05	0.000253	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.99e-05	0.000248	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—glaucoma	2.96e-05	0.000245	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCA1—glaucoma	2.96e-05	0.000245	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP1B1—glaucoma	2.96e-05	0.000245	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.78e-05	0.00023	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.76e-05	0.000228	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—glaucoma	2.37e-05	0.000196	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—glaucoma	2.36e-05	0.000196	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1B1—glaucoma	2.36e-05	0.000195	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCA1—glaucoma	2.36e-05	0.000195	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TXN—glaucoma	2.35e-05	0.000195	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—glaucoma	2.09e-05	0.000173	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOE—glaucoma	1.94e-05	0.000161	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAV1—glaucoma	1.93e-05	0.000159	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.91e-05	0.000158	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—glaucoma	1.89e-05	0.000156	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCA1—glaucoma	1.89e-05	0.000156	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1B1—glaucoma	1.89e-05	0.000156	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—glaucoma	1.83e-05	0.000151	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—glaucoma	1.67e-05	0.000138	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOE—glaucoma	1.55e-05	0.000129	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAV1—glaucoma	1.54e-05	0.000127	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—glaucoma	1.51e-05	0.000125	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—glaucoma	1.46e-05	0.000121	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCA1—glaucoma	1.45e-05	0.00012	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1B1—glaucoma	1.45e-05	0.00012	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—glaucoma	1.33e-05	0.00011	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—glaucoma	1.33e-05	0.00011	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOE—glaucoma	1.24e-05	0.000103	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAV1—glaucoma	1.23e-05	0.000102	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—glaucoma	1.16e-05	9.63e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—glaucoma	1.16e-05	9.63e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—glaucoma	1.06e-05	8.81e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—glaucoma	1.03e-05	8.51e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOE—glaucoma	9.57e-06	7.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAV1—glaucoma	9.48e-06	7.85e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—glaucoma	9.29e-06	7.69e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—glaucoma	8.5e-06	7.03e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—glaucoma	7.17e-06	5.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—glaucoma	6.56e-06	5.43e-05	CbGpPWpGaD
